Related Experiment Video
Updated: Jul 13, 2026
09:17
High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Beat shock proteins and atrial fibrillation
Harm H Kampinga1, Robert H Henning, Isabelle C van Gelder
1Department of Cell Biology, Clinical Pharmacology, and Cardiology, University Medical Center Groningen and University of Groningen, The Netherlands. h.h.kampinga@med.umcg.nl
Cell Stress & Chaperones
|August 11, 2007
Summary
Heat shock proteins (HSPs) influence atrial fibrillation (AF) susceptibility. While Hsp70 may reduce AF induction, Hsp27 (heat shock protein 27) shows potential in delaying AF progression, earning it the nickname "Beat shock protein".
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Atrial fibrillation (AF) is the most prevalent human arrhythmia, characterized by self-perpetuating and progressive nature.
- Heat shock proteins (HSPs) are a family of proteins involved in cellular stress response.
- Understanding the role of HSPs in AF pathogenesis is crucial for developing therapeutic strategies.
Purpose of the Study:
- To review the role of heat shock proteins (HSPs) in the susceptibility to and progression of atrial fibrillation (AF).
- To explore the differential impact of various HSPs on AF development and persistence.
Main Methods:
- Review of existing correlative studies in human subjects.
- Analysis of experimental studies investigating HSPs and AF.
- Examination of the expression levels of various HSPs in cardiac tissue.
Main Results:
- High expression of Hsp70 (HspA1A) in cardiac tissue correlates with reduced susceptibility to postoperative AF induction.
- Expression levels of Hsp70, Hsc70 (HspA8), Hsp40 (DnaJB1), Hsp60 (HspD1), and Hsp90 (HspC1) were not associated with AF progression.
- Hsp27 (HspB1) may delay the progression of AF to more permanent forms, suggesting a protective role.
Conclusions:
- Hsp70 expression may be protective against AF induction.
- Hsp27 demonstrates potential as a therapeutic target for mitigating AF progression.
- The role of different HSPs in AF is complex and warrants further investigation.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.